The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart Failure

Can J Cardiol. 2019 Jun;35(6):692-693. doi: 10.1016/j.cjca.2019.02.025. Epub 2019 Mar 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiomyopathy, Dilated*
  • Child
  • Heart Failure*
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein

Substances

  • Interleukin-1 Receptor-Like 1 Protein